Pulmonary Edema Market Share, Demand & Growth by 2034

Coverage: By : Type ( Heart-related Pulmonary Edema, Non-heart-related pulmonary Edema ); Type of Diagnosis ( Chest X-Ray, Pulse Oximetry, Blood Test, Imaging and others ); Treatment ( Preload Reducers, After Load Reducers, Heart Medication, Morphine, Suction Catheter, others ); End-User ( Hospitals, Clinics, Diagnostic Centers, Retail Pharmacies, others ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00017663
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Pulmonary Edema Market Share, Demand & Growth by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00017663 Email: sales@theinsightpartners.com

2025 Market Size

US$ 3.58 Bn

Base year value

2034 Forecast

US$ 4.96 Bn

Projected by 2034

CAGR 2026-2034

3.68 %

Growth rate

Addressable Market

US$ 38.77 Bn

(2026-2034)

The global pulmonary edema market size is projected to reach US$ 4.96 billion by 2034 from US$ 3.58 billion in 2025. The market is anticipated to register a CAGR of 3.68% during the forecast period 2026-2034.

Pulmonary Edema Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By : Type ( Heart-related Pulmonary Edema, Non-heart-related pulmonary Edema ); Type of Diagnosis ( Chest X-Ray, Pulse Oximetry, Blood Test, Imaging and others ); Treatment ( Preload Reducers, After Load Reducers, Heart Medication, Morphine, Suction Catheter, others ); End-User ( Hospitals, Clinics, Diagnostic Centers, Retail Pharmacies, others ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Purpose of the Report

The report Pulmonary Edema Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Pulmonary Edema Market Segmentation Type

  1. Heart-related Pulmonary Edema
  2. Non-heart-related pulmonary Edema

Type of Diagnosis

  1. Chest X-Ray
  2. Pulse Oximetry
  3. Blood Test
  4. Imaging and others

Treatment

  1. Preload Reducers
  2. After Load Reducers
  3. Heart Medication
  4. Morphine
  5. Suction Catheter
  6. others

End-User

  1. Hospitals
  2. Clinics
  3. Diagnostic Centers
  4. Retail Pharmacies
  5. others

Market Assessment and Insights

  • Global market for Pulmonary Edema was valued at US$ 3.58 Billion in 2025
  • Annual market size is expected to reach US$ 4.96 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 38.77 Billion
  • Market is anticipated to register a CAGR of 3.68% during the forecast period
  • The United States represents a key market, supported by Increasing incidence of Breast Cancer, Alcohol Consumption Among Women is Rising, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Growth Potential in Emerging Nations, Initiatives taken for Breast Cancer, Breast Cancer Fundings are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Pfizer Inc.,, Argon Medical, Edward Lifesciences Corporation, BD, Lupin Pharmaceuticals Inc., Novartis AG, Gilead Sciences Inc., Merck & Co, Jazz Pharmaceuticals Plc, Sage Therapeutics, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Pulmonary Edema Market: Strategic Insights

pulmonary-edema-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Pulmonary Edema Market Growth Drivers

  1. Increasing incidence of Breast Cancer: Globalization and growing economy has further exacerbated breast cancer incidence in developing (64% to 95) and developed (32% to 56%) nations. Breast cancer is the most common cancer in India, accounting for 28.2% of all female cancers, with an estimated 216,108 cases by 2022
  2. Alcohol Consumption Among Women is Rising: In India, where alcohol consumption among women is rising, it is crucial to be mindful of this risk. Being overweight or obese, especially after menopause, increases the risk of breast cancer. Breast cancer is the 2nd most common cancer worldwide. It is the number one cancer in women.
  3. Technologically Advancements- Various technological advancements that detects cancer at a early stage is promoting growth. These include improvements on the standard techniques (mammography, ultrasound, and MRI) as well as new platforms for breast imaging developed from body imaging tools, which include CT and radionuclide breast imaging.

Pulmonary Edema Market Future Trends

  1. Ionizing Breast Imaging Technologies: Medical exposures to radiation as well as large-scale disasters such as exposures from the atomic bomb in Japan has demonstrated that radiation can cause breast cancer. Ionizing radiation is any form of radiation with enough energy to alter an atom, such as X-rays or nuclear energy
  2. Inclusion of Artificial Intelligence : Theranostics is a currently underdeveloped nuclear medicine therapy but will become a vital tool in the future arsenal of breast radiologists. AI-assisted imaging diagnosis provides a promising perspective of a more accurate and high-efficient diagnostic model for breast cancer. The AI-system is trained on thousands of de-identified mammograms.
  3. Digital breast tomosynthesis: Digital breast tomosynthesis screening exam, which is also known as 3D mammography, has become a best practice in women's health for breast cancer-detecting technology. Breast tomosynthesis differs from traditional mammograms in how the image of the breast is obtained and viewed.

Pulmonary Edema Market Opportunities

  1. Growth Potential in Emerging Nations: Countries such as India, China, Brazil, Russia, South Korea, and Turkey have huge population base and that will spur the growth of diagnostic imaging devices market. Annual mammography and MRI screening are recommended starting at 30 years of age for women with BRCA germline mutation in China.
  2. Initiatives taken for Breast Cancer: UICC's Breast Cancer programme aims to support and strengthen the capacity of key breast cancer actors to increase their impact, with a particular focus on low- and middle-income countries, and support the achievement of the goals of the GBCI. The Global Breast Cancer Initiative, established by WHO in 2021, will provide guidance to governments on health systems strengthening for breast cancer.
  3. Breast Cancer Fundings: Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. The mission of the Breast Cancer Research Foundation is to prevent and cure breast cancer by advancing the world's most promising breast cancer research

Pulmonary Edema Market Report Scope

Report Attribute Details
Market size in 2025 US$ 3.58 Billion
Market Size by 2034 US$ 4.96 Billion
Global CAGR (2026 - 2034) 3.68%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • Heart-related Pulmonary Edema
  • Non-heart-related pulmonary Edema
By Type of Diagnosis
  • Chest X-Ray
  • Pulse Oximetry
  • Blood Test
  • Imaging and others
By Treatment
  • Preload Reducers
  • After Load Reducers
  • Heart Medication
  • Morphine
  • Suction Catheter
  • others
By End-User
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Retail Pharmacies
  • others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc.,
  • Argon Medical
  • Edward Lifesciences Corporation
  • BD
  • Lupin Pharmaceuticals Inc.
  • Novartis AG
  • Gilead Sciences Inc.
  • Merck & Co
  • Jazz Pharmaceuticals Plc
  • Sage Therapeutics

Pulmonary Edema Market Players Density: Understanding Its Impact on Business Dynamics

The Pulmonary Edema Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

pulmonary-edema-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pulmonary Edema Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Pulmonary Edema Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Asia pacific region is expected to witness the highest growth during the forecast period

In Europe, the UK held the second largest share in 2025.

Growth Potential in Emerging Nations

North America held the largest share in 2025 and is expected to retain its dominance during the forecast period

Increasing incidence of Breast Cancer

The Pulmonary Edema Market is growing at a CAGR of 3.68% from 2026 to 2034
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA